1Fujiwara K, Armstrong D, Morgan M, et al. Principles and practice of intraperitoneal chemotherapy for ovarian cancer [ J ]. Int J Gynecol Cancer,2007,17( 1 ) : 1-20.
2Hess LM, Alberts DS. The role of intraperitoneal therapy in advanced ovarian cancer [ J]. Oncology,2007, 21 (2) :227-232.
3American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer[ J]. Obstet Gynecol, 2008, 111 ( 1 ) :249-251.
4Gadducci A, Conte PF. Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature [ J ]. Int J Gynecol Cancer, 2008,10. 1111-1122.
5Elit L, Oliver TK, Covens A, et al. Intraperitoneal chemotherapy in the first-line treatment of women with stage Ⅲ epithelial ovarlan cancer: a systematic review with meta-analyses [ J ]. Cancer,2007, 109(4) :692-702.
6Hess LM, Benham-Hutchins M, Herzog TJ, et al. A meta-analysis of the efficacy of intrapefitoneal cisplatin for the front-line treatment of ovarian cancer [ J ]. Int J Gynecol Cancer, 2007, 17(3) :561-570.
7Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer[J]. N Engl J Med,2006, 354( 1 ) :34-43.
8Muggia FM. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment [ J ]. Semin Oncol, 2006, 33 (6 Suppl 12) : S18-24.
9Landrum LM, Gold MA, Moore KN, et al. Intrapefitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates [ J ]. Gynecol Oncol,2008, 108(2) :342-347.
5FIGO Cancer Committe. Stagine announcement west rerline, september 1985[J]. Gynecol Oncology, 1986,25: 283-288.
6Kuhn W, Rutke S, Sppathe K,et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in Internation Federation of Gynecology and Obstetricsstage Ⅲ Ovarian carcinoma[J]. Cancer,2001,92(10) : 2585-2591.
7Hsiang YH,Hertaberg R, Hecht S,et al. CPTIn-duces Protein-linked DNAB reaksvia mammalian DNA Topo I [J]. J Biolchem,1985, 260: 14873-14878.
9Max PD,Freddie B,Ferlay J,et al.Global cancer statistics[J].Cancer J Clin,2005,55:74-108.
10Bristow RE.Predicting surgical outcome for advanced ovarian cancer,surgical standards of care,and the concept of kaizenGynecd[J].Oncal,2009,112(1):1-3.
